Companies similar to VIRION THERAPEUTICS
Sign up to Download

1-30 of 6,474,694 results

  • www.gracellbio.com
  • 2
  • 1
Gracell Biotechnologies is a global clinical-stage biopharmaceutical company dedicated to discovering and developing innovative and highly efficacious cell therapy. Leveraging its pioneering FasTCAR and TruUCAR technology platforms, Gracell is..
Relevance: 33.41192
  • tcbiopharm.com
  • 4
  • 1
  • 7
TC BioPharm (TCBP) is a publicly traded, clinical-stage cell therapy company developing advanced allogeneic CAR-T cell therapy products for the treatment of cancer, as well as developing gamma delta T cell therapies for the treatment of infectious..
Relevance: 32.80837
  • www.barinthusbio.com
  • 1
  • 19
Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of antigen-specific immunotherapeutics that induce T cells to treat chronic viral infections, autoimmune diseases, and cancer... Barinthus..
Relevance: 31.685625
  • celularity.com
  • 24
Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent..
Relevance: 31.024994
  • kyvernatx.com
  • 7
  • 1
  • 19
Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases... Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing..
Relevance: 30.85425
  • www.eurekatherapeutics.com
  • 3
  • 1
  • 16
Eureka Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing transformative technology platforms that can access cancer-specific targets and harness the evolutionary power of T cells for the treatment of solid tumors and other..
Relevance: 30.689276
  • alaunos.com
  • 3
  • 1
  • 16
Alaunos is a clinical stage cellular immuno-oncology company dedicated to the treatment of solid tumors through adoptive TCR-T cell therapy. With our robust and innovative discovery engine, we strike cancer at its core by engineering cell therapies..
Relevance: 30.685102
  • ancorabiotech.com
Ancora Biotech LLC is a privately held company supporting the clinical development of three multi-specific antibodies. These three antibodies are held in separate spin-offs, namely: 1) TeneoTwo holds our clinical stage TNB-486 (anti-CD19xCD3) T cell..
Relevance: 29.705313
  • immunecyte.com
  • 1
  • 2
ImmuneCyte is a clinical stage cell therapy company focused on delivering critical impacts on cancer, vascular, orthopedic, and aging-related diseases... ImmuneCyte Inc. is a global, clinical-stage biopharmaceutical company engaged in the research..
Relevance: 28.567703
  • www.smart-immune.com
  • 7
  • 20
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The company was founded..
Relevance: 28.519726
  • amphivena.com
  • 1
  • 1
  • 6
Amphivena Therapeutics, Inc. is a clinical-stage, immuno-oncology company with a novel platform of T cell engagers (Amphivena ReSTORE™) that directly targets myeloid derived suppressor cells (MDSC), thus relieving cancer-induced immune suppression..
Relevance: 28.243364
  • www.liminatuspharma.com
  • 1
Liminatus Pharma is well-positioned to become a leader on Guanylyl Cyclase C (GCC) CAR-T therapeutics with a promising focus towards a GCC vaccine... We are a clinical stage immuno-oncology company that develops chimeric antigen receptors (CAR)-T..
Relevance: 27.815863
  • minktherapeutics.com
  • 1
  • 1
  • 6
MiNK Therapeutics is a clinical-stage precision oncology company developing allogeneic, invariant natural killer T cell therapies for cancer and other immune-mediated diseases. The lead product is an off-the-shelf, cell therapy based on a targeted..
Relevance: 27.654762
  • cellenkosinc.com
  • 1
  • 1
  • 7
Cellenkos was founded in 2016 with the licensing of a proprietary umbilical cord blood T-Regulatory (Tregs) cell therapy platform from MD Anderson Cancer Center and funded by Golden Meditech Holdings Ltd, a Hong Kong-based integrated healthcare..
Relevance: 27.557281
  • avencell.com
  • 4
  • 2
  • 20
AvenCell is collaborating with a number of partners committed to the joint development of novel immunotherapies based on our next generation platform technologies. We are open to exploring new clinical or strategic collaborations... AvenCell..
Relevance: 27.278006
  • poseida.com
  • 5
  • 2
  • 33
Poseida Therapeutics is a clinical-stage biopharmaceutical company advancing differentiated cell and gene therapies with the capacity to cure certain cancers and rare diseases. The Company's pipeline includes allogeneic CAR-T cell therapy product..
Relevance: 27.029694
  • www.cabalettabio.com
  • 5
  • 2
  • 22
Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Our proprietary Cabaletta Approach to B cell Ablation (CABA®) platform is designed to provide..
Relevance: 26.83689
  • www.simnovabio.com
  • 1
  • 3
Simnova is a clinical stage biotech company focusing on the development of cell therapy for cancer patients... Simnova Biotechnology was founded in 2019, which as a subsidiary of Simcere Pharmaceuticals, then spun off into an independent operating..
Relevance: 26.781313
  • www.tspotcovid.com
A leading global diagnostics company with a nearly 20-year history of transforming T cell science into meaningful insights using the T-SPOT Technology. The T-SPOT Technology is proven in TB diagnostics with > 20 million tests shipped to > 50..
Relevance: 26.55573
  • www.viriontx.com
  • 1
  • 1
  • 11
Virion Therapeutics is a clinical-stage company developing novel T cell-based immunotherapies for cancer and chronic infectious diseases. We utilize genetically encoded checkpoint modifiers (CPM) to enhance and broaden CD8+ T cell responses to a..
Relevance: 26.284185
  • www.liontcr.com
  • 5
  • 3
  • 8
Lion TCR is a clinical-stage biotechnology company dedicated to the continued development and commercialization of our TCR-T therapy... For the past decade, we have accumulated expertise covering the entire product development process, ranging from..
Relevance: 26.276272
  • www.lindisbiotech.com
  • 1
  • 1
  • 2
Lindis Biotech is a clinical stage bio-pharmaceutical company, committed to develop innovative T- cell engaging trifunctional bispecific antibodies, Triomab® to turn malignant cancers into manageable and possibly curable diseases... Lindis Biotech..
Relevance: 26.248909
  • mynanostilbene.com
NanoStilbene Clinical Trial - These results suggest that NanoStilbene may be a useful adjuvant to immunotherapy of cancer rescuing T cell and NK cell activities...
Relevance: 26.239798
  • www.lintonpharm.com
  • 3
LintonPharm Co., Ltd. is a clinical-stage, research-oriented biopharmaceutical company committed to developing innovative T cell engaging bispecific antibodies with the goal of becoming the worldwide leader in CD3 bispecific antibody. LintonPharm, in..
Relevance: 25.739635
  • www.carsgen.com
  • 3
  • 9
CARsgen is a biopharmaceutical company with operations in China and the U.S. and is focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors. The Company has built an integrated cell therapy platform..
Relevance: 25.68359
  • med.stanford.edu
  • 24
  • 17
  • 141
The Stanford Multidisciplinary Cutaneous and T-cell Lymphoma team offers expert treatment for patients with cutaneous or systemic T-cell lymphomas, including mycosis fungoides (MF), Sézary syndrome (SS), CD30+ lymphoproliferative disorders..
Relevance: 25.530237
  • www.repertoire.com
  • 3
  • 1
  • 21
Repertoire Immune Medicines is a biotechnology company dedicated to designing and developing immune medicines based on the power of the human T cell repertoire to address cancer, autoimmune disorders and infectious diseases... Repertoire Immune..
Relevance: 25.428719
  • immatics.com
  • 4
  • 9
  • 39
Immatics is a clinical-stage biopharmaceutical company active in the discovery and development of T cell redirecting immunotherapies for the treatment of cancer. Immatics is sponsoring several clinical trials to deliver the power of T cells to cancer..
Relevance: 25.350147
  • herlinglab.com
  • 1
  • 3
  • 2
Our laboratory focuses on targetable molecular events of malignant lymphocyte transformation and evaluation of such pathway dependence, with particular interest in the pathogenetic mechanisms of chronic lymphoid leukemias. These comprise a..
Relevance: 25.21827
  • cytoart.com
  • 2
  • 1
Cytoart is a biotechnology company aimed at improving the development, quality control and clinical monitoring of CAR T-cell therapies. By offering our comprehensive anti-idiotypic platform, we are a leading provider of companion diagnostics for CAR..
Relevance: 25.180786